• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. International Journal of Pharmacology
  2. Vol 17 (7), 2021
  3. 442-454
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

International Journal of Pharmacology

Year: 2021 | Volume: 17 | Issue: 7 | Page No.: 442-454
DOI: 10.3923/ijp.2021.442.454

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 402

Authors


Yang Kui

Country: China

Ding Yanyun

Country: China

Jin Wan

Country: China

Wang Yaqin

Country: China

Chen Lu

Country: China

Zhang Wen

Country: China

Wang Wusan

Country: China

Ma Zhangqing

Country: China

Luan  Jiajie

Luan Jiajie

LiveDNA: 86.35745

Keywords


  • angiotensin
  • BP rhythm
  • circadian rhythm
  • hypothalamus
  • Melatonin
  • mRNA expression
  • non-dipping hypertension
  • valsartan
Research Article

Combination of Valsartan and Melatonin to Treat Non-Dipping Hypertension Rats via Circadian Clock System

Yang Kui, Ding Yanyun, Jin Wan, Wang Yaqin, Chen Lu, Zhang Wen, Wang Wusan, Ma Zhangqing and Luan Jiajie Luan  Jiajie's LiveDNA
Background and Objective: Researches have reported that valsartan or melatonin bedtime administration showed a positive therapy to treat non-dipping Blood Pressure (BP), respectively. However, the combined effect of these two drugs in the treatment of non-dipping BP is unknown. Thus, this work aimed to evaluate the combined effects of valsartan and melatonin in the treatment of Spontaneous Hypertension Rats (SHR) with non-dipping BP and to explore its potential mechanism. Materials and Methods: A total of 28 male Wistar-Kyoto rats (WKY) was utilized as a non-disease control. A total of 144 male SHRs were treated with valsartan (10 mg/kg/day) combined with or without melatonin (20 mg/kg/day) after light onset. The 24 hrs BP, ANG II, ET-1, NO, Per1 and Per2 mRNA levels were detected. Nonlinear regression was used to calculate parameters of circadian BP rhythm. Inter-group means were compared using a One-Way Analysis Of Variance (ANOVA). Results: Valsartan administration with or without melatonin can significantly reduce active BP, restored circadian BP rhythm. Moreover, combination therapy reduced plasma levels of ANG II, ET-1 and NO, restored circadian rhythm ANG II in SHR rats and down-regulated the expression of Per1 mRNA in the aorta abdominalis. Conclusion: Melatonin combined with valsartan significantly reduced BP and restored circadian BP rhythm than a single drug. The mechanism may associates with decreased Per genes expression and recover circadian rhythm of plasma ANG II.
PDF Fulltext XML References Citation

How to cite this article

Yang Kui, Ding Yanyun, Jin Wan, Wang Yaqin, Chen Lu, Zhang Wen, Wang Wusan, Ma Zhangqing and Luan Jiajie, 2021. Combination of Valsartan and Melatonin to Treat Non-Dipping Hypertension Rats via Circadian Clock System. International Journal of Pharmacology, 17: 442-454.

DOI: 10.3923/ijp.2021.442.454

URL: https://scialert.net/abstract/?doi=ijp.2021.442.454

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved